InvestorsHub Logo
Followers 94
Posts 5890
Boards Moderated 1
Alias Born 01/09/2014

Re: JohnCM post# 3622

Saturday, 01/20/2018 10:15:59 AM

Saturday, January 20, 2018 10:15:59 AM

Post# of 6315
There's so much trash out there with $100M, even $300M market caps. This won't have any trouble reaching those levels.

We should make a list of development stage cannabis biotechs with market caps for comparison.

The easiest target off hand is Lexaria. $100M+ and they are probably a scam, no experience at CEO, no human trials.

Something happened - which unleashed the power of our imagination...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SKYE News